Clinical Trial Update: Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the probiotic BIFILACT® for reducing diarrhea in patients undergoing pelvic radiation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Diarrhea

Drugs mentioned

• BIFILACT®

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Cancer, Diarrhea | Phase 3 | Status: COMPLETED